MENU
IMCR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Immunocore Holdings (IMCR) Ownership - Who owns Immunocore Holdings?
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases... Show more
Profile
Industry
N/A
Address
92 Park Drive
Phone
+44 1235438600
Employees
497
Web
https://www.immunocore.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.45B
P/E Ratio
N/A
Total Cash
901.28M
Projected Growth
N/A
Total Debt
481.06M
Revenue
296.31M
Risk (Beta)
0.80
Dividend Yield
N/A
Total Cash/Share
18.00
Total Debt/Equity
N/A
Revenue/Share
6.21 USD as % of share price
Fundamentals
IMCR
Capitalization
1.45B
P/E Ratio
N/A
Risk (Beta)
0.80
Dividend Yield
N/A
Total Cash
901M
Total Cash/Share
18.00
Total Debt
481M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.21%
Revenue
296M
ROE
N/A
Book Value
378M
P/B Ratio
4.08
Cash Flow
N/A
Earnings
-0.95
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
135K
Current Ratio
3.78
Current Revenue Per Employee
161464.78
Dividends Per Share - Security
N/A
EBITDA
-37.92M
Float
N/A
Float - Current
N/A
Gross Income Margin
99.44
Revenue To Assets
-5.70
Shares Held By Institutions
2.51B
Shares Outstanding - Current
50.1M
Total Liabilities
707M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-0.441
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
92 Park Drive
Phone
+44 1235438600
Employees
497
Web
https://www.immunocore.com